Answers are grounded in this paper and cite their sources.
Pathological scars have long been considered a product of sterile chronic inflammation but the theory is inadequate to account for the observed differences, invasiveness, or treatment resistance of pathological scars. There is growing evidence that the skin microbiome might play a role in skin fibrosis and also alter with tissue remodelling. In this review, we will explore the possibility that microbial dysbiosis can play a role in pathological scar formation. We discuss the ecological transition from homeostatic colonisation to chronic dysbiosis and the possible involvement of biofilm formation in chronic, non-healing wounds as well as tissue-associated bacterial signalling and its potential association with altered host immunity and chronic inflammation. Here, we also discuss the possibility of deep-tissue dysbiosis including enrichment of anaerobic and catalase negative taxa and how it may lead to the induction of oxidative stress and activation of fibroblasts via the transforming growth factor-β (TGF-β)/Smad and NF-κB signalling pathways. The gut-skin axis and potential systemic role of metabolites produced by gut microbes on fibrotic responses in the skin are discussed. We evaluate the new microbiome therapies and the difficulties of implementing them clinically.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: